ExodusPoint Capital Management’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-70,142
Closed -$877K – 2035
2026
Q2
$877K Buy
+70,142
New +$940K 0.01% 1108
2026
Q1
– Sell
-150,670
Closed -$3.77M – 1946
2025
Q4
$3.77M Buy
+150,670
New +$2.68M 0.03% 576
2025
Q3
– Sell
-58,980
Closed -$251K – 1880
2025
Q2
$251K Buy
+58,980
New +$263K ﹤0.01% 1276
2025
Q1
– Sell
-91,298
Closed -$532K – 1846
2024
Q4
$532K Buy
91,298
+21,457
+31% +$214K ﹤0.01% 1137
2024
Q3
$834K Buy
+69,841
New +$893K 0.01% 1023
2022
Q1
– Sell
-30,677
Closed -$287K – 2547
2021
Q4
$287K Buy
+30,677
New +$636K ﹤0.01% 1676
2021
Q1
– Sell
-21,629
Closed -$1.04M – 2465
2020
Q4
$1.04M Buy
+21,629
New +$1.01M 0.01% 841

Other funds holding OLMA

ExodusPoint Capital Management's OLMA Position: Q3 2026 in Review

ExodusPoint Capital Management sold out of Olema Oncology (OLMA) in Q3 2026, closing a stake of 70,142 shares — an estimated $877K sold.

ExodusPoint Capital Management first reported a position in OLMA in Q4 2020 and held it in 7 quarters. The position peaked at $3.77M in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • ExodusPoint Capital Management reported no remaining Olema Oncology position as of Q3 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 70,142 Olema Oncology shares in Q3 2026, an estimated $877K.
  • ExodusPoint Capital Management first reported a position in Olema Oncology in Q4 2020 and held it in 7 quarters.
  • ExodusPoint Capital Management's Olema Oncology position peaked at $3.77M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.